Bluejay Diagnostics, Inc.
BJDX
$1.66
-$0.11-6.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.25M | -7.72M | -8.59M | -9.40M | -9.74M |
| Total Depreciation and Amortization | 196.70K | 199.10K | 217.90K | 435.10K | 674.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 321.30K | 331.90K | 817.70K | 583.30K | -15.40K |
| Change in Net Operating Assets | 27.30K | -636.80K | -1.31M | 330.00K | 1.40M |
| Cash from Operations | -6.71M | -7.82M | -8.86M | -8.06M | -7.68M |
| Capital Expenditure | -271.30K | -306.70K | -393.50K | -467.80K | -398.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -271.30K | -306.70K | -393.50K | -467.80K | -398.90K |
| Total Debt Issued | 2.00M | 2.00M | 2.00M | 2.00M | -- |
| Total Debt Repaid | -2.00M | -2.00M | -2.29M | -1.92M | -4.50K |
| Issuance of Common Stock | 8.57M | 12.07M | 12.07M | 13.66M | 5.09M |
| Repurchase of Common Stock | -400.00 | -400.00 | -- | 0.00 | -1.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.13M | -1.84M | -1.85M | -2.26M | -1.13M |
| Cash from Financing | 7.43M | 10.22M | 9.93M | 11.48M | 3.96M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 454.90K | 2.09M | 678.80K | 2.96M | -4.12M |